Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) traded at $0.32 at close of the session on Tuesday, January 28 and made a downward move of -6.16% on its previous day’s price.
Looking at the stock we see that its previous close was $0.34 and the beta (5Y monthly) reads 1.886 with the day’s price range being $0.3067 – $0.3339. In terms of its 52-week price range, QNRX has a high of $6.18 and a low of $0.34. The company’s stock has lost about -34.03% over that past 30 days.
Quoin Pharmaceuticals Ltd ADR has a market cap of $1.62 million and is expected to release its quarterly earnings report in February.
On the other hand, looking at the outlook for the QNRX stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell.
Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Quoin Pharmaceuticals Ltd ADR (QNRX) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is -43.81% off its SMA20 and -47.99% from its 50-day simple moving average. The RSI (14) is pointing at 27.78 while the volatility over the past week is 22.68% and jumps to 14.91% over the past one month. The beta value is 1.74, while the average true range (ATR) is currently pointing at 0.08.
Coming back to Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX), we note that the average 3-month trading volume was 2.46 million, while that of the preceding 10-day period stands at 7.12 million. Current shares outstanding are 5.05 million.
